中西医结合肝病杂志2024,Vol.34Issue(4) :292-295,300.DOI:10.3969/j.issn.1005-0264.2024.004.002

基于"肝为气之治"理论探讨肝硬化全病程中医防治机理及实践

Exploring the mechanism and practice of traditional Chinese medicine prevention and treatment for the whole course of liver cirrhosis based on the theory of"Liver Qi Restricts the Whole Body Qi"

谭梅傲 黄祎 刘姝婉 王雅楠 刘华宝
中西医结合肝病杂志2024,Vol.34Issue(4) :292-295,300.DOI:10.3969/j.issn.1005-0264.2024.004.002

基于"肝为气之治"理论探讨肝硬化全病程中医防治机理及实践

Exploring the mechanism and practice of traditional Chinese medicine prevention and treatment for the whole course of liver cirrhosis based on the theory of"Liver Qi Restricts the Whole Body Qi"

谭梅傲 1黄祎 1刘姝婉 1王雅楠 1刘华宝1
扫码查看

作者信息

  • 1. 重庆市中医院肝病科 (重庆,50000);全国名中医刘华宝工作室
  • 折叠

摘要

本文围绕全国名中医刘华宝教授提出的"肝为气之治"探讨肝硬化的病因病机,从防重于治的前瞻谋划、多维度布局的用药特点,探讨肝硬化失代偿诊疗难点,提出肝硬化需重视风险评估及"多学科协作"构建慢性肝病管理模式等观点.以期提高中医对肝硬化的认识,并部分指导中西医结合精准治疗.

Abstract

This treatise scrutinizes the concept of"Liver restricts the Qi"as promulgated by the illustrious Professor Liu Huabao,an expert in traditional Chinese medicine of national renown,with the intent of delving into the causation and pathogenesis of liver cirrhosis.Viewing the matter through the prism of favoring prophylactic strategies over therapeutic reactions,and the intricacies inherent in the multi-faceted distribution of pharmacological solutions,the discussion herein addresses the formidable challenges that present themselves in the diagnosis and treatment of decompensated liver cirrhosis.It advocates for heightened vigilance in risk assessment and the establishment of an integrative"multidisciplinary collaborative"management framework for the continuum of chronic liver ailments.The aim of this exposition is to augment the comprehension of liver cirrhosis within the sphere of traditional Chinese medicine,and to some extent,shepherd the meticulous application of a synergistic approach combining traditional Chinese and Western medical practices.

关键词

肝硬化/肝为气之治/学术经验

Key words

Liver cirrhosis/Liver as Qi Treatment/Academic experience

引用本文复制引用

基金项目

全国名中医传承工作室项目(渝财社[2023]43号)

成都中医药大学杏林学者科研提升计划(国中医药人教函[2021]202号)

成都中医药大学杏林学者科研提升计划(YYZX2021056)

国家自然科学基金青年基金(82204953)

中国博士后科学基金(2022M710552)

重庆市自然科学基金—博士后项目(CSTB2022NSCQ-BHX0032)

中医药防治肝纤维化传承创新团队项目(渝中医[2022]33号)

中医药防治肝纤维化传承创新团队项目(渝中央财政补助社[2023]43)

出版年

2024
中西医结合肝病杂志
中国中西医结合学会,湖北中医学院

中西医结合肝病杂志

CSTPCD
影响因子:0.908
ISSN:1005-0264
被引量1
参考文献量12
段落导航相关论文